It's time to phase in<i><scp>RHD</scp></i>genotyping for patients with a serologic weak<scp>D</scp>phenotypeS. Gerald Sandler, Clayton D. Simon, Willy A. Flegel et al.|Transfusion|2014Cited by 195
Partial D, weak D types, and novel<i>RHD</i>alleles among 33,864 multiethnic patients: implications for anti‐D alloimmunization and preventionGregory A. Denomme, Willy A. Flegel, Franz F. Wagner et al.|Transfusion|2005Cited by 125
International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: Report of the Dubai, Copenhagen and Toronto meetingsJill R. Storry, Vered Yahalom, Connie M. Westhoff et al.|Vox Sanguinis|2018Cited by 99
International society of blood transfusion working party on red cell immunogenetics and terminology: report of the Seoul and London meetingsJill R. Storry, Vered Yahalom, Lilian Castilho et al.|ISBT Science Series|2016Cited by 82
Implementing mass‐scale red cell genotyping at a blood centerWilly A. Flegel, Gregory A. Denomme, Jerome L. Gottschall|Transfusion|2015Cited by 74